Introduction
Berberine is one of the most extensively studied botanical ingredients in the nutraceutical industry due to its established role in supporting glucose and lipid metabolism, cardiovascular health, and overall metabolic wellness. In recent years, growing scientific interest has also focused on its interaction with the gut microbiota and liver health.
Despite its significant nutraceutical value, Berberine presents important formulation challenges, primarily related to its extremely bitter taste, which can negatively affect product acceptance and consumer compliance.
To address these challenges, IPS has developed Berberine MATRIS® and Berberine MINIACTIVES®, two complementary solutions based on the proprietary and patented MATRIS® and MINIACTIVES® technologies, designed to improve sensory acceptance while expanding formulation possibilities.
Properties and application fields of Berberine
Berberine is widely used in nutraceutical formulations dedicated to:
- Glucose metabolism support
Included in products designed to help maintain metabolic balance. - Lipid metabolism
Frequently used in formulations supporting cardiovascular wellness. - Liver support
Included in nutraceutical solutions dedicated to normal liver physiology. - Intestinal wellness
Increasingly investigated for its interaction with the gut microbiota.
Formulation challenges of Berberine
The use of Berberine in nutraceutical formulations is limited by several intrinsic characteristics:
- Extremely bitter taste, often poorly accepted by consumers
- Persistent aftertaste, particularly in solid and orodispersible dosage forms
- Challenges in developing multi-ingredient formulations while maintaining high sensory acceptance
- Need for consistent technological quality during industrial manufacturing
These limitations highlight the importance of dedicated microencapsulation technologies.
IPS innovation: Berberine MATRIS® and Berberine MINIACTIVES®
IPS offers two complementary technological approaches designed to meet different formulation requirements.
Berberine MATRIS®
Produced through direct microencapsulation of the active ingredient using proprietary and patented MATRIS® technology, it provides:
- effective taste masking, significantly reducing bitterness
- improved sensory acceptance
- enhanced industrial processability
- better integration into complex formulations
Berberine MINIACTIVES®
Produced using proprietary and patented MINIACTIVES® technology, it offers:
- effective taste masking
- excellent active-ingredient distribution uniformity
- high formulation flexibility
- adaptable solutions for different dosage requirements
Both technologies are designed to improve sensory acceptance without altering the nature of Berberine.
Scientific evidence
IPS technological platforms are supported by robust scientific evidence.
For MATRIS®, preclinical studies conducted on advanced in vitro 3D models and human intestinal and gastric organoids, using other active ingredients processed with the same technology, demonstrated:
- improved interaction with the intestinal epithelium
- reduced impact on gastric membranes
- improved tolerability
- increased bioaccessibility
For MINIACTIVES®, clinical studies performed on Coenzyme Q10 MINIACTIVES® and Citicoline MINIACTIVES® demonstrated:
- improved release profile
- increased bioaccessibility
- improved tolerability
Although these studies were not conducted directly on Berberine, the results confirm that the observed benefits are attributable to the microencapsulation technologies themselves, which represent the determining factor in the behavior of the formulated active ingredient.
Formulations and applications
Berberine MATRIS® and Berberine MINIACTIVES® are suitable for:
- capsules
- tablets
- sachets and stick packs
- dosing-cap vials
- SmarTTabs®, technological innovation by IPS for direct compression, preserving the technological characteristics of each platform.
This versatility enables the development of advanced metabolic-health formulations with excellent technological quality and improved sensory acceptance.
Conclusion
Berberine is one of the most valuable botanical ingredients in modern nutraceuticals, yet its intense bitterness remains one of its main formulation challenges.
With Berberine MATRIS® and Berberine MINIACTIVES®, IPS provides two complementary technological platforms capable of significantly improving sensory acceptance, formulation quality, and development flexibility.
The MATRIS® and MINIACTIVES® technologies further confirm the role of the SURACTIVES® division of IPS as a technology provider in the development of innovative, high-performance, and scientifically supported nutraceutical ingredients.
Note: This article is provided for informational purposes only and does not substitute professional medical advice.
